Failure of Sulfonamides and Trimethoprim in the Treatment of Nocardiosis

Authors:
  • ASAlan M. Stamm
    Alan M. Stamm
  • DMDanny W. McFall
    Danny W. McFall
  • WDWilliam E. Dismukes
    William E. Dismukes

Abstract
• An immunocompromised patient withNocardia brasiliensispneumonia and empyema acquired disseminated disease due toNocardia asteroidesand died. The treatment of choice for pulmonary or disseminated nocardiosis is 6 to 12 g/day of sulfisoxazole (or adjusted dosage to achieve a serum level of 100 to 150 mg/L) continued for six to 18 months. Combination therapy may be beneficial in selected patients; if trimethoprim therapy is used with sulfonamides, higher than usual doses of trimethoprim may be required to achieve optimal antinocardial activity. When the condition of a patient with nocardiosis fails to improve on sulfonamide therapy, patient compliance should be questioned, serum sulfonamide levels should be measured, cultures and susceptibility studies should be repeated, and a search for sequestered pus should be made. (Arch Intern Med1983;143:383-385)